AQST FY 2017 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$67M+29.2% YoY

Gross Profit

$47M70.4% margin

Operating Income

-$113,000-0.2% margin

Net Income

-$9M-13.4% margin

EPS (Diluted)

$-0.45

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$43M

Total Liabilities

$70M

Stockholders' Equity

-$26M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$52M	+29.2%
Gross Profit	$47M	$35M	+33.0%
Operating Income	-$113,000	-$847,000	+86.7%
Net Income	-$9M	-$10M	+6.9%